Employees: 03 (2023.0)Legal category: 5485Size: PMECreation date: 2011-09-06 (14 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: POINTE-NOIRE (97116), Guadeloupe
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
PHARMACIE PIQUION-WYCKMANS : revenue, balance sheet and financial ratios
PHARMACIE PIQUION-WYCKMANS is a French company
founded 14 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in POINTE-NOIRE (97116),
this company of category PME
shows in 2022 a net income positive of 167 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE PIQUION-WYCKMANS (SIREN 534490644)
Indicator
2022
2021
2020
Revenue
N/C
N/C
N/C
Net income
167 368 €
184 979 €
156 389 €
EBITDA
N/C
N/C
N/C
Net margin
N/C
N/C
N/C
Revenue and income statement
In 2022, PHARMACIE PIQUION-WYCKMANS generates positive net income of 167 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2020-2022: 156 k€ -> 167 k€.
Net income (2022)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
167 368 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 115%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 42%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2022)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
114.682%
Financial autonomy (2022)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
42.311%
Asset age ratio (2022)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2020
2021
2022
Debt ratio
199.878
150.674
114.682
Financial autonomy
29.53
35.766
42.311
Repayment capacity
None
None
None
Cash flow / Revenue
None%
None%
None%
Sector positioning
Debt ratio
114.682022
2020
2021
2022
Q1: 24.5
Med: 74.73
Q3: 182.59
Average-9 pts over 3 years
In 2022, the debt ratio of PHARMACIE PIQUION-WYCKMANS (114.68) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
42.31%2022
2020
2021
2022
Q1: 28.53%
Med: 47.06%
Q3: 66.62%
Average+10 pts over 3 years
In 2022, the financial autonomy of PHARMACIE PIQUION-WYCKMANS (42.3%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 74.82. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2022)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2020
2021
2022
Liquidity ratio
205.678
213.181
74.822
Interest coverage
None
None
None
Sector positioning
Liquidity ratio
74.822022
2020
2021
2022
Q1: 145.2
Med: 199.49
Q3: 275.01
Watch-45 pts over 3 years
In 2022, the liquidity ratio of PHARMACIE PIQUION-WYCKMANS (74.82) ranks in the bottom 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio below 1 may signal potential cash flow tensions.
Positioning of PHARMACIE PIQUION-WYCKMANS in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 215 transactions of similar company sales
in 2022,
the value of PHARMACIE PIQUION-WYCKMANS is estimated at
1 969 337 €
(range 1 323 785€ - 2 953 639€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2022
215 transactions
1323k€1969k€2953k€
1 969 337 €Range: 1 323 785€ - 2 953 639€
NAF 5 année 2022
Valuation method used
Net Income Multiple
167 368 €
×
11.8x
=1 969 337 €
Range: 1 323 786€ - 2 953 640€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 215 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE PIQUION-WYCKMANS with other companies in the same sector:
Frequently asked questions about PHARMACIE PIQUION-WYCKMANS
What is the revenue of PHARMACIE PIQUION-WYCKMANS ?
The revenue of PHARMACIE PIQUION-WYCKMANS is not publicly disclosed (confidential accounts filed with INPI).
Is PHARMACIE PIQUION-WYCKMANS profitable?
Yes, PHARMACIE PIQUION-WYCKMANS generated a net profit of 167 k€ in 2022.
Where is the headquarters of PHARMACIE PIQUION-WYCKMANS ?
The headquarters of PHARMACIE PIQUION-WYCKMANS is located in POINTE-NOIRE (97116), in the department Guadeloupe.
Where to find the tax return of PHARMACIE PIQUION-WYCKMANS ?
The tax return of PHARMACIE PIQUION-WYCKMANS is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE PIQUION-WYCKMANS operate?
PHARMACIE PIQUION-WYCKMANS operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart